(NasdaqGM:NBP), Givastomig, a CLDN18.2 x 4-1BB bispecific antibody, continues to show robust efficacy when combined with nivolumab and chemotherapy (mFOLFOX6) in 1L HER2-negative, metastatic gastric cancer patients, with 77% ORR observed at 8 mg/kg and 73% ORR observed at 12 mg/kg, across a wide range of PD-L1 and CLDN18.2 expression levels The median PFS was […]

(NASDAQ:LTRX), LAS VEGAS, Jan. 06, 2026 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions powering Edge AI applications, today announced the debut of its new SmartEdge.ai(TM) 5G-ready Edge AI Gateway and SmartSwitch.ai(TM) PoE+ aggregation switch with onboard AI capabilities. The solutions form an integrated Edge AI surveillance

VICTORIA, Seychelles, Jan. 06, 2026 (GLOBE NEWSWIRE) — BitMEX, one of the safest exchanges, today announced the launch of Equity Perps, a new derivatives product that allows traders to gain exposure to major U.S. stocks and equity indices using cryptocurrency as collateral. The launch expands BitMEX's product suite beyond crypto-native markets, enabling 24/7 trading on

Aarhus, Denmark, 6 January 2026 – NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel and improved treatments for patients living with neuromuscular diseases, today announces that Thomas Holm Pedersen, Chief Executive Officer of NMD Pharma, has been invited to present at the 44th Annual J.P. Morgan Healthcare Conference, taking place from 12-15

Key Mining Corp., a Global Critical Minerals and Infrastructure Company, and Compass Digital Acquisition Corp. Announce Definitive Merger Agreement GlobeNewswire January 06, 2026 Key Mining Corp. (“KMC” or the “Company”) is a global critical minerals and infrastructure company focused on acquiring, advancing and developing assets in the Americas with projects in Chile and the United

Gain Therapeutics Highlights Biomarker Evidence Supporting Disease-Modifying Potential of GT-02287 Results to be discussed in KOL event today at 10 a.m. ET GlobeNewswire January 06, 2026 BETHESDA, Md., Jan. 06, 2026 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next

Coda Octopus Group Sets Fiscal Year 2025 Earnings Conference Call for Thursday, January 29, 2026, at 10 a.m. Eastern Time GlobeNewswire January 06, 2026 Orlando, FL, Jan. 06, 2026 (GLOBE NEWSWIRE) — Coda Octopus Group, Inc. (“CODA” or the “Company”) (NASDAQ: CODA), a global market leader in real-time 3D/4D/5D and 6D imaging sonar technology for

EVTV Executes Transformational AZIO AI Acquisition Framework at $3.00 Per Share EVTV Board of Directors Approves Amended and Restated LOI with AZIO AI at $3.00 Per Share, Subject to Independent Third-Party Valuation GlobeNewswire January 06, 2026 HOUSTON, Jan. 06, 2026 (GLOBE NEWSWIRE) — via IBN — Envirotech Vehicles, Inc. (NASDAQ:EVTV) (“EVTV” or the “Company”) today

Aurora Mobile's GPTBots.ai Partners with Echosens China to Improve Efficiency and Service Quality in Non-Invasive Liver Diagnostics GlobeNewswire January 06, 2026 SHENZHEN, China, Jan. 06, 2026 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that its

Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72 GlobeNewswire January 06, 2026 FDA clearance enables initiation of Abpro's first clinical-stage solid tumor program Clinical trial anticipated to commence in the first half of 2026 through Abpro's global collaboration with Celltrion BURLINGTON, Mass. and INCHEON, South